The Clinical Impact of the Pulmonary Embolism Severity Index on the Length of Hospital Stay of Patients with Pulmonary Embolism: A Randomized Controlled Trial MP Donadini, N Mumoli, P Fenu, F Pomero, R Re, G Palmiero, ... Diagnostics 14 (7), 776, 2024 | | 2024 |
Use of artificial intelligence and radiomics for risk stratification in patients with pulmonary embolism: New tools for an old problem D Santagata, MP Donadini, W Ageno European Journal of Clinical Investigation, e14171, 2024 | | 2024 |
Rates of Venous Thromboembolism and use of thromboprophylaxis after major orthopedic surgery in patients with congenital Hemophilia A or B: a systematic review D Santagata, A Abenante, A Squizzato, F Dentali, MP Donadini, W Ageno, ... Journal of Thrombosis and Haemostasis, 2024 | | 2024 |
Geographical and ethnoracial differences in venous thromboembolism and anticoagulation: An expanding horizon N Potere, MP Donadini, W Ageno European Journal of Internal Medicine 118, 43-45, 2023 | 3 | 2023 |
Short versus long-term anticoagulation for left ventricular thrombosis resolution during vitamin k antagonist therapy E Valeriani, D Pastori, G Astorri, W Ageno, MP Donadini, DP Santagata, ... European Heart Journal 44 (Supplement_2), ehad655. 1372, 2023 | | 2023 |
PB1411 Study of Endothelial Dysfunction in Patients with Unprovoked Venous Thromboembolism through Endothelial Colony-Forming Cell In Vitro Characterization A Cancellara, M Bacci, R Ciceri, E Romualdi, V Pessi, F Tumminello, ... Research and Practice in Thrombosis and Haemostasis 7, 101676, 2023 | | 2023 |
OC 12.3 Rates of Venous Thromboembolism and use of Thromboprophylaxis After Major Orthopedic Surgery in Patients with Congenital Hemophilia A or B: A Systematic Review D Santagata, A Abenante, A Squizzato, M Donadini, F Dentali, W Ageno, ... Research and Practice in Thrombosis and Haemostasis 7, 2023 | | 2023 |
Venous and arterial thromboembolic risk of Janus kinase inhibitors: a systematic review with meta-analysis F Campanaro, A Zaffaroni, E Cacioppo, A Cappelli, L Bertù, MP Donadini, ... Rheumatology 62 (10), 3245-3255, 2023 | 4 | 2023 |
DOACs use in extreme body-weighted patients: results from the prospective START-register M Guarascio, L Bertù, MP Donadini, E Antonucci, G Palareti, W Ageno Internal and Emergency Medicine 18 (6), 1681-1687, 2023 | 2 | 2023 |
Factor XI inhibitors for the prevention of cardiovascular disease: A new therapeutic approach on the horizon? D Santagata, MP Donadini, W Ageno Blood Reviews, 101119, 2023 | 5 | 2023 |
Development of Personalized Thrombogenesis and Thrombin Generation Assays to Assess Endothelial Dysfunction in Cardiovascular Diseases M Bacci, A Cancellara, R Ciceri, E Romualdi, V Pessi, F Tumminello, ... Biomedicines 11 (6), 1669, 2023 | 1 | 2023 |
Antithrombotic treatment for retinal vein occlusion: a systematic review and meta-analysis E Valeriani, F Paciullo, A Porfidia, P Pignatelli, M Candeloro, M Di Nisio, ... Journal of Thrombosis and Haemostasis 21 (2), 284-293, 2023 | 8 | 2023 |
Il tromboembolismo venoso nel paziente oncologico D Santagata, MP Donadini | | 2023 |
Incidence and impact of anticoagulation-associated abnormal menstrual bleeding in women after venous thromboembolism CMM de Jong, M Blondon, C Ay, A Buchmuller, J Beyer-Westendorf, ... Blood, The Journal of the American Society of Hematology 140 (16), 1764-1773, 2022 | 21 | 2022 |
Current and emerging drug strategies for the prevention of venous thromboembolism in acutely ill medical inpatients D Santagata, G Cammà, MP Donadini, A Squizzato, W Ageno Expert Opinion on Pharmacotherapy 23 (14), 1651-1665, 2022 | 1 | 2022 |
Antithrombotic treatment of retinal vein occlusion: a position statement from the Italian Society on Thrombosis and Haemostasis (SISET) F Paciullo, E Valeriani, A Porfidia, M Di Nisio, MP Donadini, R Marcucci, ... Blood Transfusion 20 (4), 341, 2022 | 15 | 2022 |
Rivaroxaban for the treatment of noncirrhotic splanchnic vein thrombosis: an interventional prospective cohort study W Ageno, J Beyer Westendorf, L Contino, E Bucherini, MT Sartori, ... Blood Advances 6 (12), 3569-3578, 2022 | 26 | 2022 |
TEMPORARY REMOVAL: PO-43: Pharmacological thromboprophylaxis to prevent venous thromboembolism in ambulatory patients with cancer undergoing antineoplastic drugs in real world … MP Donadini, A Squizzato, P Ferrazzi, S Maggioni, C Sacco, C Lodigiani Thrombosis Research 213, S30-S31, 2022 | | 2022 |
PO-43: Pharmacological thromboprophylaxis to prevent venous thromboembolism in ambulatory patients with cancer undergoing antineoplastic drugs in real world clinical practice … MP Donadini, A Squizzato, P Ferrazzi, S Maggioni, C Sacco, C Lodigiani Thrombosis Research 213, S30-S31, 2022 | | 2022 |
Milvexian and other drugs targeting Factor XI: a new era of anticoagulation? MP Donadini, W Ageno Bleeding, Thrombosis and Vascular Biology 1 (1), 2022 | 2 | 2022 |